Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that UnityPoint Health, an integrated non-profit health system that provides care throughout Iowa, western Illinois and southern Wisconsin in not-for-profit hospitals, clinics, and home health settings, is set to migrate from Health Catalyst's […]

(NASDAQ:HCAT), SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter of 2025, I am pleased by our financial results, including

(NYSE:NGS), MIDLAND, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the three months ended September 30, 2025. The Company also provided updated guidance today, increasing both

Health Catalyst Reports Third Quarter 2025 Results GlobeNewswire November 10, 2025 SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter

Natural Gas Services Group, Inc. Reports Third Quarter 2025 Financial and Operating Results; Increases 2025 Adjusted EBITDA Guidance GlobeNewswire November 10, 2025 MIDLAND, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry,

(NASDAQ:FGEN), Completed the sale of FibroGen China to AstraZeneca for approximately $220 million Initiated the Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC) Reached agreement with the U.S. Food and Drug Administration (FDA) on important design elements for the pivotal Phase 3 trial

FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 10, 2025 Completed the sale of FibroGen China to AstraZeneca for approximately $220 million Initiated the Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC) Reached agreement with the U.S. Food

Paramount Skydance Corporation (Nasdaq: PSKY) today announced financial results for the third quarter ended September 30, 2025. Please visit the Paramount Investors homepage to view a letter to shareholders. A live audio webcast will be available onParamount'sInvestors homepage atir.paramount.combeginning at1:30 p.m. (PT) / 4:30 p.m. (ET)onNovember 10. The conference call can also be accessed by

CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner® (“CleanSpark” or the “Company”), today announced that it intends to offer, subject to market conditions and other factors, $1 billion aggregate principal amount of convertible senior notes due 2032 (the “Convertible Notes”) to the initial purchasers for resale in a private offering to persons reasonably believed to be

CarParts.com,Inc.(NASDAQ: PRTS), a leading eCommerce provider of automotive parts and accessories, and a premier destination for vehicle repair and maintenance needs, is reporting results for the third quarter endedSeptember 27, 2025. https://mma.prnewswire.com/media/2449535/Carparts_logo.jpg Third Quarter 2025Summary vs. Year-Ago Quarter — Net sales decreased 12% to $127.8 million. — Gross profit of $42.3 million vs. $51.0 million,